Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection

Infection and Immunity

Volumn 76, Issue 9, 2008, Pages 4222-4231

  Nielubowicz, Greta R ^a   Smith, Sara N ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; PMI 0047; PMI 0288; PMI 0842; PMI 1810; PMI 2596; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMORAL IMMUNITY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEUS MIRABILIS; SERUM; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINARY TRACT INFECTION; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; COLONY COUNT, MICROBIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE DELETION; HUMANS; MASS SPECTROMETRY; MICE; MICE, INBRED CBA; PROTEUS MIRABILIS; URINARY TRACT INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 51949092341     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00533-08     Document Type: Article

References (64)

1. Afonina, G., I. Leduc, I. Nepluev, C. Jeter, P. Routh, G. Almond, P. E. Orndorff, M. Hobbs, and C. Elkins. 2006. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect. Immun. 74:2224-2232.
2. Alamuri. P., and H. L. Mobley. 2008. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol. Microbiol. 68:997-1017.
3. Allocati, N., B. Favaloro, M. Masulli, M. F. Alexeyev, and C. Di Ilio. 2003. Proteus mirabilis glutathione S-transferase Bl-1 is involved in protective mechanisms against oxidative and chemical stresses. Biochem. J. 373:305-311.
4. Alteri, C. J., and H. L. Mobley. 2007. Quantitative profile of the uropatho-genic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75:2679-2688.
5. Andersen, C, D. Krones, C. Ulmke, K. Schmid, and R. Benz. 1998. The porin RafY encoded by the raffinose plasmid pRSD2 of Escherichia coli forms a general diffusion pore and not a carbohydrate-specific porin. Eur. J. Biochem. 254:679-684.
6. Bacheller, C. D., and J. M. Bernstein. 1997. Urinary tract infections. Med. Clin. N. Am. 81:719-730.
7. Bahrani, F. K., and H. L. Mobley. 1994. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression. J. Bacteriol. 176:3412-3419.
8. Belas, R. 1994. Expression of multiple flagellin-encoding genes of Proteus mirabilis. J. Bacteriol. 176:7169-7181.
9. Belas, R., and D. Flaherty. 1994. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene 148:33-41.
10. Bertot, G. M., P. D. Becker, C. A. Guzman, and S. Grinstein. 2004. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. J. Infect. Dis. 189:1304-1312.
11. Bouvier, J., A. P. Pugsley, and P. Stragier. 1991. A gene for a new lipoprotein in the dapA-purC interval of the Escherichia coli chromosome. J. Bacteriol. 173:5523-5531.
12. Burall, L. S., J. M. Harm, X. Li, C. V. Lockatell, S. D. Himpsl, J. R. Hebel, D. E. Johnson, and H. L. Mobley. 2004. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect. Immun. 72:2922-2938.
13. Burnens. A., U. Stucki, J. Nicolet, and J. Frey. 1995. Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni. J. Clin. Microbiol. 33:2826-2832.
14. Davanloo, P., A. H. Rosenberg, J. J. Dunn, and F. W. Studier. 1984. Cloning and expression of the gene for bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 81:2035-2039.
15. DeMaria, T. F., D. M. Murwin, and E. R. Leake 1996. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect. Immun. 64:5187-5192.
16. Eggert, U. S., N. Ruiz, B. V. Falcone, A. A. Branstrom, R. C. Goldman, T. J. Silhavy, and D. Kahne. 2001. Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science 294:361-364.
17. Engleberg, N. C., D. C. Howe, J. E. Rogers, J. Arroyo, and B. I. Eisenstein. 1991. Characterization of a Legionella pneumophila gene encoding a lipoprotein antigen. Mol. Microbiol. 5:2021-2029.
18. Eriksson, K., and J. Holmgren. 2002. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 14:666-672.
19. Forst, D., W. Welte, T. Wacker, and K. Diederichs. 1998. Structure of the sucrose-specific porin ScrY from Salmonella typhimurium and its complex with sucrose. Nat. Struct. Biol. 5:37-46.
20. Gaisser, S., and C. Hughes. 1997. A locus coding for putative non-ribosomal peptide/polyketide synthase functions is mutated in a swarming-defective Proteus mirabilis strain. Mol. Gen. Genet. 253:415-427.
21. Gerding, M. A., Y. Ogata, N. D. Pecora, H. Niki, and P. A. de Boer. 2007. The trans-envelope Tol-Pal complex is part of the cell division machinery and required for proper outer-membrane invagination during cell constriction in E. coli. Mol. Microbiol. 63:1008-1025.
22. Hagan, E. C., and H. L. Mobley. 2007. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75:3941-3949.
23. Hagberg, L., I. Engberg, R. Freter, J. Lam, S. Oiling, and C. Svanborg Eden. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
24. Hajishengallis, G., S. K. Hollingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154:4322-4332.
25. Hellman, J., J. D. Roberts, Jr., M. M. Tehan. J. E. Allaire, and H. S. Warren. 2002. Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice. J. Biol. Chem. 277:14274-14280.
26. Hotomi, M., T. Saito, and N. Yamanaka. 1998. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine 16:1950-1956.
27. Johnson, D. E., F. K. Bahrani, C. V. Lockatell, C. B. Drachenberg, J. R. Hebel, R. Belas, J. W. Warren, and H. L. Mobley. 1999. Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection. Infect. Immun. 67:6683-6687.
28. Johnson, D. E., C. V. Lockatell, M. Hall-Craigs, H. L. Mobley, and J. W. Warren. 1987. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J. Urol. 138:632-635.
29. Johnson, D. E., C. V. Lockatell, R. G. Russell, J. R. Hebel, M. D. Island, A. Stapleton, W. E. Stamm, and J. W. Warren. 1998. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect. Immun. 66:3059-3065.
30. Kyd, J. M., M. L. Dunkley, and A. W. Cripps. 1995. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect. Immun. 63:2931-2940.
31. Legnani-Fajardo, C, P. Zunino, G. Algorta, and H. F. Laborde. 1991. Antigenic and immunogenic activity of fiagella and fimbriae preparations from uropathogenic Proteus mirabilis. Can. J. Microbiol. 37:325-328.
32. Li, X., J. L. Erbe, C. V. Lockatell, D. E. Johnson, M. G. Jobling, R. K. Holmes, and H. L. Mobley. 2004. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coex-pressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect. Immun. 72:7306-7310.
33. Li, X., C. V. Lockatell, D. E. Johnson, M. C. Lane, J. W. Warren, and H. L. Mobley. 2004. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect. Immun. 72:66-75.
34. Li, X., and H. L. Mobley. 2002. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents 19:461-465.
35. Li, X., H. Zhao, C. V. Lockatell, C. B. Drachenberg, D. E. Johnson, and H. L. Mobley. 2002. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect. Immun. 70:389-394.
36. Lima, A., P. Zunino, B. D'Alessandro, and C. Piccini. 2007. An iron-regulated outer-membrane protein of Proteus mirabilis is a haem receptor that plays an important role in urinary tract infection and in in vivo growth. J. Med. Microbiol. 56:1600-1607.
37. Lloubes, R., E. Cascales, A. Walburger, E. Bouveret, C. Lazdunski, A. Ber nadac, and L. Journet. 2001. The Tol-Pal proteins of the Escherichia coli cell envelope: an energized system required for outer membrane integrity? Res. Microbiol. 152:523-529.
38. Manos, J., and R. Betas. 2004. Transcription of Proteus mirabilis flaAB. Microbiology 150:2857-2863.
39. Moayeri, N., C. M. Collins, and P. O'Hanley. 1991. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect. Immun. 59:3778-3786.
40. Mobley, H. L., and G. R. Chippendale. 1990. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J. Infect. Dis. 161:525-530.
41. Mobley, H. L., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217.
42. Molloy, M. P., B. R. Herbert, M. B. Slade, T. Rabilloud, A. S. Nouwens, K. L. Williams, and A. A. Gooley. 2000. Proteomic analysis of the Escherichia coli outer membrane. Eur. J. Biochem. 267:2871-2881.
43. Molloy, M. P., B. R. Herbert, K. L. Williams, and A. A. Gooley. 1999. Extraction of Escherichia coli proteins with organic solvents prior to two-dimensional electrophoresis. Electrophoresis 20:701-704.
44. Murphy, C. A., and R. Belas. 1999. Genomic rearrangements in the flagellin genes of Proteus mirabilis. Mol. Microbiol. 31:679-690.
45. Pearson, M. M., and H. L. Mobley. 2007. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J. Med. Microbiol. 56:1277-1283.
46. Pearson, M. M., M. Sebaihia, C. Churcher, M. A. Quail, A. S. Seshasayee, Z. Abdellah, C. Arrosmith, B. Atkin, T. Chillingworth, H. Hauser, K. Jagels, S. Moule, K. Mungall, H. Norbertczak, E. Rabbinowitsch, D. Walker, S. Whithead, N. R. Thomson, P. N. Rather, J. Parkhill, and H. L. Mobley. 2008. The complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190:4027-4037.
47. Pellegrino, R., U. Galvalisi, P. Scavone, V. Sosa, and P. Zunino. 2003. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol. Med. Microbiol. 36:103-110.
48. Piccini, C. D., F. M. Barbe, and C. L. Legnani-Fajardo. 1998. Identification of iron-regulated outer membrane proteins in uropathogenic Proteus mirabilis and its relationship with heme uptake. FEMS Microbiol. Lett. 166:243-248.
49. Ruiz, N., B. Falcone, D. Kahne, and T. J. Silhavy. 2005. Chemical condi-tionality: a genetic strategy to probe organelle assembly. Cell 121:307-317.
50. Russo, T. A., C. D. McFadden, U. B. Carlino-MacDonald, J. M. Beanan, R. Olson, and G. E. Wilding. 2003. The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect. Immun. 71:7164-7169.
51. Scavone, P., A. Miyoshi, A. Rial, A. Chabalgoity, P. Langella, V. Azevedo, and P. Zunino. 2007. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Microbes Infect. 9:821-828.
52. Scavone, P., V. Sosa, R. Pellegrino, U. Galvalisi, and P. Zunino. 2004. Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins. Microbes Infect. 6:853-860.
53. Schirmer, T., T. A. Keller, Y. F. Wang, and J. P. Rosenbusch. 1995. Structural basis for sugar translocation through maltoporin channels at 3.1 A resolution. Science 267:512-514.
54. Shand, G. H., H. Anwar, J. Kadurugamuwa, M. R. Brown, S. H. Silverman, and J. Melling. 1985. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect. Immun. 48:35-39.
55. Snyder, J. A., B. J. Haugen, E. L. Buckles, C. V. Lockatell, D. E. Johnson, M. S. Donnenberg, R. A. Welch, and H. L. Mobley. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72:6373-6381.
56. Sturgis, J. N. 2001. Organisation and evolution of the tol-pal gene cluster. J. Mol. Microbiol. Biotechnol. 3:113-122.
57. Tambyah, P. A., and D. G. Maki. 2000. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch. Intern. Med. 160:678-682.
58. Thumbikat, P., C. Waltenbaugh, A. J. Schaeffer, and D. J. Klumpp. 2006. Antigen-specific responses accelerate bacterial clearance in the bladder. J. Immunol. 176:3080-3086.
59. Torres, A. G., P. Redford, R. A. Welch, and S. M. Payne. 2001. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 69:6179-6185.
60. van den Berg, B., P. N. Black, W. M. demons. Jr., and T. A. Rapoport. 2004. Crystal structure of the long-chain fatty acid transporter FadL. Science 304:1506-1509.
61. Warren, J. W., J. H. Tenney, J. M. Hoopes, H. L. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146:719-723.
62. Webb, D. C., and A. W. Cripps. 1999. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung. Infect. Immun. 67:2138-2144.
63. Wu, T., J. Malinverni, N. Ruiz, S. Kim, T. J. Silhavy, and D. Kahne. 2005. Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell 121:235-245.
64. Zhao, H., X. Li, D. E. Johnson, I. Blomfield, and H. L. Mobley. 1997. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23:1009-1019.